You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

275 Results
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Document
Oct 2021
Drug
Other Name(s): Mylotarg®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2022
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    gilteritinib - Relapsed or Refractory FLT3-mutated acute myeloid leukemia
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
gilteritinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2022
Document
Feb 2022
Document
Feb 2022

Pages